Clinical Trials on Amyloidosis AA
Total 549 results
-
Turkish Society of CardiologyRecruiting
-
Medical College of WisconsinTerminatedCardiac AmyloidosisUnited States
-
Brigham and Women's HospitalTerminatedCardiac AmyloidosisUnited States
-
University of MessinaCampisi MariapaolaUnknownCardiac AmyloidosisItaly
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Seoul National University HospitalCW pharmaceutical companyUnknownCardiac AmyloidosisKorea, Republic of
-
Virginia Commonwealth UniversityNot yet recruitingAmyloidosis, HereditaryUnited States
-
Nanjing University School of MedicineRecruiting
-
Oncology Institute of Southern SwitzerlandUniversity of Kiel; Ente Ospedaliero Cantonale, BellinzonaCompleted
-
Attralus, Inc.Novotech (Australia) Pty LimitedRecruitingAmyloidosis; SystemicUnited States, Australia, United Kingdom
-
Brigham and Women's HospitalRecruiting
-
University of Tennessee Graduate School of MedicineActive, not recruitingSystemic AmyloidosisUnited States
-
The Cleveland ClinicAvid RadiopharmaceuticalsTerminatedCardiac AmyloidosisUnited States
-
University Hospital Center of MartiniquePfizerUnknownCardiac AmyloidosisGuadeloupe, Martinique
-
University of EdinburghUnknown
-
Shahid Beheshti University of Medical SciencesCompleted
-
Rennes University HospitalRecruitingTransthyretin Amyloidosis | Amyloidosis, HereditaryFrance
-
Air Force Military Medical University, ChinaNot yet recruitingImmunoglobulin Light-chain Amyloidosis
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
National Cancer Institute (NCI)TerminatedPrimary Systemic AmyloidosisUnited States
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, United Kingdom
-
University of PennsylvaniaAstraZeneca; Ionis Pharmaceuticals, Inc.Active, not recruitingHereditary Amyloidosis, Transthyretin-RelatedUnited States
-
Ionis Pharmaceuticals, Inc.Approved for marketingAmyloidosis, Hereditary
-
Alnylam PharmaceuticalsRecruitingTransthyretin-Mediated AmyloidosisUnited Kingdom
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Spain, Sweden, Brazil, United States, France, Germany
-
IRCCS Policlinico S. MatteoCompleted
-
Alnylam PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited Kingdom
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
-
Federico II UniversityEnrolling by invitation
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Sweden, Brazil, United States, France, Spain, Germany
-
Chulalongkorn UniversityRatchadapiseksompotch FundUnknownLichen AmyloidosisThailand
-
University Hospital, LimogesMinistry of Health, FranceCompletedPrimary Systemic Amyloidosis (AL)France
-
Oregon Health and Science UniversityAttralus, Inc.RecruitingAmyloidosis | Transthyretin AmyloidosisUnited States
-
GCS Ramsay Santé pour l'Enseignement et la RechercheRecruiting
-
Wuhan Union Hospital, ChinaRecruiting
-
Attralus, Inc.CompletedAmyloidosis; SystemicUnited States
-
Prothena Biosciences LimitedTerminatedAmyloidogenic Transthyretin (ATTR) AmyloidosisUnited States, Spain, Sweden, Portugal
-
Fábio FernandesPfizerUnknown
-
PfizerCompletedTransthyretin-associated Amyloidosis With PolyneuropathyUnited States, France, Germany, Italy
-
Seoul National University HospitalCompletedAmyloidosis CardiacKorea, Republic of
-
Boston Medical CenterSpectrum Pharmaceuticals, IncTerminatedAmyloidosis; SystemicUnited States
-
Alnylam PharmaceuticalsRecruitingTransthyretin-Mediated Amyloidosis | ATTR AmyloidosisIsrael, Italy, Netherlands, Spain, United States, France, Denmark, Germany, Portugal, Brazil, Taiwan
-
Mayo ClinicRecruitingHealthy Adults | Amyloidosis CardiacUnited States
-
Alnylam PharmaceuticalsCompletedTransthyretin Mediated Amyloidosis (ATTR)United Kingdom, France, Portugal, Sweden
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, Canada, United Kingdom
-
Jin Lu, MDRecruitingAL Amyloidosis | Amyloidosis; SystemicChina
-
National Cancer Institute (NCI)CompletedPrimary Systemic Amyloidosis | Light Chain Deposition DiseaseUnited States
-
Zhejiang UniversityRecruitingTransthyroxin Amyloidosis CardiomyopathyChina